Focal Lesions of the Liver and Radiomics: What Do We Know?
Despite differences in pathological analysis, focal liver lesions are not always distinguishable in contrast-enhanced magnetic resonance imaging (MRI), contrast-enhanced computed tomography (CT), and positron emission tomography (PET). This issue can cause problems of differential diagnosis, treatme...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/13/15/2591 |
| _version_ | 1797586887892795392 |
|---|---|
| author | Matilde Anichini Antonio Galluzzo Ginevra Danti Giulia Grazzini Silvia Pradella Francesca Treballi Eleonora Bicci |
| author_facet | Matilde Anichini Antonio Galluzzo Ginevra Danti Giulia Grazzini Silvia Pradella Francesca Treballi Eleonora Bicci |
| author_sort | Matilde Anichini |
| collection | DOAJ |
| description | Despite differences in pathological analysis, focal liver lesions are not always distinguishable in contrast-enhanced magnetic resonance imaging (MRI), contrast-enhanced computed tomography (CT), and positron emission tomography (PET). This issue can cause problems of differential diagnosis, treatment, and follow-up, especially in patients affected by HBV/HCV chronic liver disease or fatty liver disease. Radiomics is an innovative imaging approach that extracts and analyzes non-visible quantitative imaging features, supporting the radiologist in the most challenging differential diagnosis when the best-known methods are not conclusive. The purpose of this review is to evaluate the most significant CT and MRI texture features, which can discriminate between the main benign and malignant focal liver lesions and can be helpful to predict the response to pharmacological or surgical therapy and the patient’s prognosis. |
| first_indexed | 2024-03-11T00:29:32Z |
| format | Article |
| id | doaj.art-8b05dcc5fac141d3a3128383aff811b5 |
| institution | Directory Open Access Journal |
| issn | 2075-4418 |
| language | English |
| last_indexed | 2024-03-11T00:29:32Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj.art-8b05dcc5fac141d3a3128383aff811b52023-11-18T22:47:33ZengMDPI AGDiagnostics2075-44182023-08-011315259110.3390/diagnostics13152591Focal Lesions of the Liver and Radiomics: What Do We Know?Matilde Anichini0Antonio Galluzzo1Ginevra Danti2Giulia Grazzini3Silvia Pradella4Francesca Treballi5Eleonora Bicci6Department of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDepartment of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDepartment of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDepartment of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDepartment of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDepartment of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDepartment of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, ItalyDespite differences in pathological analysis, focal liver lesions are not always distinguishable in contrast-enhanced magnetic resonance imaging (MRI), contrast-enhanced computed tomography (CT), and positron emission tomography (PET). This issue can cause problems of differential diagnosis, treatment, and follow-up, especially in patients affected by HBV/HCV chronic liver disease or fatty liver disease. Radiomics is an innovative imaging approach that extracts and analyzes non-visible quantitative imaging features, supporting the radiologist in the most challenging differential diagnosis when the best-known methods are not conclusive. The purpose of this review is to evaluate the most significant CT and MRI texture features, which can discriminate between the main benign and malignant focal liver lesions and can be helpful to predict the response to pharmacological or surgical therapy and the patient’s prognosis.https://www.mdpi.com/2075-4418/13/15/2591livercontrast-enhanced computed tomography (CT)contrast-enhanced magnetic resonance (MRI)radiomicstexture features |
| spellingShingle | Matilde Anichini Antonio Galluzzo Ginevra Danti Giulia Grazzini Silvia Pradella Francesca Treballi Eleonora Bicci Focal Lesions of the Liver and Radiomics: What Do We Know? Diagnostics liver contrast-enhanced computed tomography (CT) contrast-enhanced magnetic resonance (MRI) radiomics texture features |
| title | Focal Lesions of the Liver and Radiomics: What Do We Know? |
| title_full | Focal Lesions of the Liver and Radiomics: What Do We Know? |
| title_fullStr | Focal Lesions of the Liver and Radiomics: What Do We Know? |
| title_full_unstemmed | Focal Lesions of the Liver and Radiomics: What Do We Know? |
| title_short | Focal Lesions of the Liver and Radiomics: What Do We Know? |
| title_sort | focal lesions of the liver and radiomics what do we know |
| topic | liver contrast-enhanced computed tomography (CT) contrast-enhanced magnetic resonance (MRI) radiomics texture features |
| url | https://www.mdpi.com/2075-4418/13/15/2591 |
| work_keys_str_mv | AT matildeanichini focallesionsoftheliverandradiomicswhatdoweknow AT antoniogalluzzo focallesionsoftheliverandradiomicswhatdoweknow AT ginevradanti focallesionsoftheliverandradiomicswhatdoweknow AT giuliagrazzini focallesionsoftheliverandradiomicswhatdoweknow AT silviapradella focallesionsoftheliverandradiomicswhatdoweknow AT francescatreballi focallesionsoftheliverandradiomicswhatdoweknow AT eleonorabicci focallesionsoftheliverandradiomicswhatdoweknow |